U.S. halts distribution of Eli Lilly’s coronavirus antibody treatment bamlanivimab as a monotherapy

The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab (LY-CoV555) as a monotherapy just four months after it received FDA emergency use authorization, citing a sustained increase in variants of SARS-CoV-2 that are resistant to the monotherapy.  More...

Denmark suspends AstraZeneca coronavirus vaccinations for another 3 weeks

The pause for vaccination with the COVID-19 vaccine from AstraZeneca is extended by 3 weeks

The Danish Health and Medicines Authority is extending the break with the COVID-19 vaccine from AstraZeneca, because the assessment of the use of the vaccine in the Danish vaccination program against COVID-19 is still ongoing.  More...